Fresenius Medical Care AG & Co. KGaA (FME.DE) Stock Analysis & Winston Score

Fresenius Medical Care is the world's largest provider of kidney dialysis services and products. It runs dialysis clinics where patients with kidney failure go several times a week to have their blood cleaned by machines. The company also makes and sells the dialysis machines, filters, and fluids that clinics around the world use. The company earns money two ways: by charging for dialysis treatments at its own clinics, and by selling dialysis equipment and supplies to other healthcare providers. It operates thousands of clinics across North America, Europe, Asia, and Latin America, serving roughly 340,000 patients globally. Its scale and the fact that dialysis patients need ongoing, life-sustaining treatment create a steady, recurring revenue stream that is hard for smaller competitors to match. The main risk is that reimbursement rates — what governments and insurers pay per treatment — are under constant pressure, which squeezes profit margins and limits how much the company can earn per patient visit.